BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34930176)

  • 1. Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells.
    Fujishima F; Fukuhara N; Katsushima H; Nakamura Y; Harigae H; Sasano H; Ichinohasama R
    BMC Cancer; 2021 Dec; 21(1):1352. PubMed ID: 34930176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better method for detection of CD30: Immunohistochemistry or flow cytometry?
    Higashi M; Kikuchi J; Murakami C; Takayanagi N; Momose S; Kizaki M; Tamaru JI
    J Clin Exp Hematop; 2021 Dec; 61(4):221-223. PubMed ID: 34511584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of mature T-cell and NK-cell lymphoma with CD30 expression based on latest WHO classification].
    Feng Y; Fu J; Yan S; Ling Y; Huang Y; Cai M; Rao H
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):508-11. PubMed ID: 25346118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.
    Debliquis A; Baseggio L; Bouyer S; Guy J; Garnache-Ottou F; Genevieve F; Mayeur-Rousse C; Letestu R; Chapuis N; Harrivel V; Bennani H; Lachot S; Loosveld M; Nicolino-Brunet C; Pérès M; Roussel M; Veyrat-Masson R; Jacob MC; Drenou B
    Cytometry B Clin Cytom; 2021 Jul; 100(4):488-496. PubMed ID: 32803917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical pattern of c-MYC protein judged as "+/(weak)+/-" by a new notation correlates with MYC gene nontranslocation in large B-cell lymphoma.
    Fujishima F; Katsushima H; Fukuhara N; Konosu-Fukaya S; Nakamura Y; Usubuchi H; Sato S; Ota Y; Yashima-Abo A; Nakamura T; Nakaya N; Harigae H; Sasano H; Ichinohasama R
    Hum Pathol; 2019 Mar; 85():112-118. PubMed ID: 30448222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy.
    Kawamoto K; Miyoshi H; Suzuki T; Sasaki Y; Yamada K; Yanagida E; Muto R; Kiryu M; Sone H; Seto M; Ohshima K; Takizawa J
    Hematol Oncol; 2018 Feb; 36(1):166-173. PubMed ID: 29052238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.
    Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
    Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Flow-Cytometry-Based Immunophenotyping Analysis for Accurate Diagnosis and Management of Extranodal NK/T Cell Lymphoma, Nasal Type.
    Wang JC; Deng XQ; Liu WP; Gao LM; Zhang WY; Yan JQ; Ye YX; Liu F; Zhao S
    Cytometry B Clin Cytom; 2020 Jan; 98(1):28-35. PubMed ID: 31313887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
    Nakashima M; Uchimaru K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 expression in follicular lymphoma.
    Gardner LJ; Polski JM; Evans HL; Perkins SL; Dunphy CH
    Arch Pathol Lab Med; 2001 Aug; 125(8):1036-41. PubMed ID: 11473453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes.
    Vega F; Medeiros LJ
    Hum Pathol; 2020 Aug; 102():104-116. PubMed ID: 32479842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
    Tomaszewski MM; Moad JC; Lupton GP
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology.
    Fitzpatrick MJ; Massoth LR; Marcus C; Vergilio JA; Severson E; Duncan D; Ramkissoon SH; Hasserjian RP; Kim AS; Sohani AR; Williams EA; Nardi V
    Am J Surg Pathol; 2021 Jul; 45(7):895-904. PubMed ID: 34105517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
    Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
    Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
    Romaguera JE; Garcia-Foncillas J; Cabanillas F
    Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High intratumoural galectin-1 expression predicts adverse outcome in ALK
    Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
    Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.